INCY Incyte Corporation - Common Stock
$125.49
株価 · 8月 19, 2026
ファンダメンタルズ（時点） 7月 28, 2026
Incyte Corporation - Common Stock について Wikipediaからの企業概要
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
続きを読む
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.
History
Incyte Corporation was founded by Roy A. Whitfield on April 8, 1991, in Palo Alto, California, as a genomics company. It became a public company in 1993. Subsequently, scientists and chemists were recruited from DuPont to work for Incyte. Incyte moved its headquarters to Delaware, and acquired Maxia Pharmaceuticals in 2003.
In November 2013, Incyte announced its relocation to new headquarters in Wilmington, Delaware, completing the move by the end of 2014. Hervé Hoppenot became CEO in January 2014.
In 2017, the company became part of the S&P 500 Index, which tracks the 500 most widely held U.S. stocks.
In 2015, Incyte established its European headquarters in Geneva, Switzerland, and later moved this headquarters in 2021. The company expanded its Delaware headquarters, including the addition of a research and development facility, in 2022. Incyte acquired Villaris Therapeutics in 2022, and Escient Pharmaceuticals in 2024.
For 2025, the company reported $5.141 billion in revenue, $6.957 billion in assets and $1.286 billion in net income. Incyte is publicly traded on the NASDAQ under the symbol INCY. Incyte now operates out of North America, Asia, and Europe. Bill Meury became CEO in 2025. Meury replaced Hoppenot, who retired after 11 years in the position.
Pharmaceuticals
Incyte Corporation currently has seven marketed and co-marketed pharmaceutical products, including Jakafi (ruxolitinib), Pemazyre (pemigatinib), Monjuvi (tafasitamab-cxix), Opzelura (Ruxolitinib), Tabrecta (capmatinib), Olumiant (Baricitinib), and Iclusig (ponatinib).
In 2013, Novartis acquired Incyte's c-Met inhibitor capmatinib (INC280, INCB028060), which is marketed under the brand name Tabrecta.
As of 2014, the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017. In April 2017, the US FDA issued a rejection, citing concerns about dosing and safety. In May 2018, baricitinib was approved in the United States for the treatment of rheumatoid arthritis under the brand name Olumiant.
As of 2016 epacadostat, an indoleamine 2,3-dioxygenase (IDO1) inhibitor, was in development for various cancers and was in combination trials with Merck's pembrolizumab (Keytruda) and Bristol Myers Squibb's nivolumab (Opdivo).
Acquisition history
Incyte has made a total of 3 acquisitions.
Maxia Pharmaceuticals (2003): An early acquisition in Incyte's history, the company purchased Maxia in 2003 for $42 million.
Villaris Therapeutics (2022): This acquisition was valued at approximately $1.4 billion and included an upfront payment along with milestones. It added new assets to Incyte's portfolio for treating vitiligo and other autoimmune conditions.
Escient Pharmaceuticals (2024): In May 2024, Incyte acquired this San Diego-based, clinical-stage company for $750 million. The acquisition provided Incyte with two oral drug candidates for inflammatory diseases, EP262 and EP547.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
INCY 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$125.48
時価総額
$24.90B
P/E (TTM)
19.6
EPS（TTM）
$6.41
収益（TTM）
$5.14B
配当利回り
—
ROE
27.6%
負債/自己資本
—
52週レンジ
$81 – $133
INCY 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
Configure
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益と純利益
$5.14B
2016-12-31
→
2025-12-31
EPS
$6.41
2016-12-31
→
2025-12-31
フリーキャッシュフロー
—
2017-12-31
→
2022-12-31
利益率
25.0%
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
指標
5年トレンド
INCY
競合中央値
P/E (TTM)
19.6
17.7
P/S (TTM) (株価売上高倍率（TTM）)
4.8
6.8
P/B (株価純資産倍率)
4.8
6.4
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
指標
5年トレンド
INCY
競合中央値
Operating Margin (営業利益率)
29.5%
—
Net Profit Margin (純利益率)
25.0%
20.3%
ROA
20.8%
11.4%
ROE
27.6%
16.8%
ROIC
22.7%
—
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
指標
5年トレンド
INCY
競合中央値
Current Ratio (流動比率)
3.3
3.4
Quick Ratio (クイックレシオ)
2.0
—
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
指標
5年トレンド
INCY
競合中央値
Revenue YoY (収益（前年比）)
21.2%
—
Revenue CAGR 3Y (収益（3年CAGR）)
14.8%
—
Revenue CAGR 5Y (収益（5年CAGR）)
14.0%
—
EPS YoY
4173.3%
—
Net Income YoY (純利益（前年比）)
3845.0%
—
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
指標
5年トレンド
INCY
競合中央値
INCY アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
買い
33 アナリスト
- 強い買い 8 24.2%
- 買い 9 27.3%
- 保有 16 48.5%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
23 アナリスト · 2026-08-18
中央値
$120.00
現在
$125.48
安値
$86.00
高値
$155.00
中央値ターゲット
$120.00
-4.4%
平均値ターゲット
$125.17
-0.2%
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
0.33%
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $3.09 | $2.14 | 0.95% |
| 2026年3月31日 | $1.81 | $1.40 | 0.41% |
| 2025年12月31日 | $1.80 | $1.97 | -0.17% |
| 2025年9月30日 | $2.26 | $1.69 | 0.57% |
| 2025年6月30日 | $1.57 | $1.50 | 0.07% |
| 2025年3月31日 | $1.16 | $1.04 | 0.12% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| RVMD | — | — | — | — | — | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 17
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Cost of Revenue | $372M | $312M | $255M | $207M | $151M | $131M | $114M | $94M | $79M | $58M | $27M | $3M | |
| R&D Expense | $2.05B | $2.61B | $1.63B | $1.59B | $1.46B | $2.22B | $1.15B | $1.20B | $1.33B | $582M | $480M | $348M | |
| SG&A Expense | $1.38B | $1.24B | $1.16B | $1.00B | $740M | $517M | $469M | $434M | $366M | $303M | $197M | $166M | |
| Operating Expenses | $3.63B | $4.18B | $3.08B | $2.82B | $2.40B | $2.93B | $1.76B | $1.75B | $1.78B | $961M | $703M | $516M | |
| Operating Income | $1.51B | $61M | $621M | $579M | $586M | $-264M | $402M | $129M | $-243M | $145M | $51M | $-5M | |
| Interest Expense | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $7M | $39M | $46M | $47M | |
| Interest Income | $106M | $129M | $158M | $40M | · | · | · | · | · | · | · | · | |
| Other Non-op | $25M | $13M | $14M | $-519.0K | $11M | $23M | $52M | $32M | $17M | · | · | · | |
| Pretax Income | $1.66B | $317M | $834M | $529M | $570M | $-232M | $487M | $115M | $-312M | $107M | $8M | $-49M | |
| Income Tax | $378M | $284M | $237M | $188M | $-378M | $63M | $40M | $6M | $852.0K | $3M | $1M | $-66.0K | |
| Net Income | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| EPS (Basic) | $6.59 | $0.16 | $2.67 | $1.53 | $4.30 | $-1.36 | $2.08 | $0.52 | $-1.53 | $0.55 | $0.04 | $-0.29 | |
| EPS (Diluted) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | $-1.36 | $2.05 | $0.51 | $-1.53 | $0.54 | $0.03 | $-0.29 | |
| Shares (Basic) | 195,204,000 | 207,110,000 | 223,628,000 | 222,004,000 | 220,428,000 | 218,073,000 | 214,913,000 | 212,383,000 | 204,580,000 | 187,873,000 | 179,601,000 | 167,947,000 | |
| Shares (Diluted) | 200,700,000 | 210,530,000 | 225,928,000 | 223,958,000 | 222,074,000 | 218,073,000 | 217,657,000 | 215,635,000 | 204,580,000 | 194,125,000 | 187,302,000 | 167,947,000 | |
| EBITDA | $1.61B | $151M | · | $647M | $644M | $-212M | $457M | $184M | $-192M | · | · | $37M |
貸借対照表 27
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.10B | $1.69B | $3.21B | $2.95B | $2.06B | $1.51B | $1.83B | $1.16B | $900M | $652M | $521M | $452M | |
| Short-term Investments | · | · | · | · | · | · | $285M | $274M | $270M | $156M | $186M | $148M | |
| Inventory | $101M | $59M | $63M | $42M | $28M | $16M | $11M | $7M | $6M | $4M | $2M | $358.0K | |
| Prepaid Expense | $318M | $169M | $183M | $167M | $126M | $60M | $44M | $79M | $62M | $33M | $18M | $21M | |
| Current Assets | $5.02B | $3.24B | $4.65B | $4.09B | $3.12B | $2.36B | $2.48B | $1.83B | $1.50B | $994M | $842M | $680M | |
| PP&E (Net) | $731M | $763M | $752M | $739M | $724M | $560M | $378M | $320M | $260M | $168M | $86M | $82M | |
| PP&E (Gross) | $1.11B | $1.09B | $1.02B | $952M | $900M | $704M | $499M | $423M | $334M | $219M | $131M | $116M | |
| Accum. Depreciation | $375M | $328M | $270M | $213M | $176M | $144M | $122M | $103M | $75M | $52M | $45M | $35M | |
| Goodwill | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | $237M | $270M | $12M | $2M | |
| Other Non-current Assets | $18M | $11M | $52M | $25M | $37M | $39M | $49M | $19M | $2M | $3M | $12M | · | |
| Total Assets | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Accounts Payable | $210M | $197M | $110M | $278M | $172M | $99M | $84M | $104M | $68M | $76M | $30M | $24M | |
| Accrued Liabilities | $1.03B | $1.21B | $936M | $701M | $534M | $378M | $286M | $229M | $199M | $127M | $87M | $62M | |
| Current Liabilities | $1.52B | $1.64B | $1.24B | $1.16B | $854M | $631M | $513M | $425M | $375M | $274M | $168M | $221M | |
| Capital Leases | $15M | $17M | $14M | $14M | $16M | $14M | $12M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $20M | |
| Other Non-current Liabilities | $165M | $168M | $149M | $99M | $70M | $58M | $40M | $22M | $20M | $13M | $48M | $55M | |
| Total Liabilities | $1.79B | $2.00B | $1.59B | $1.47B | $1.16B | $950M | $828M | $720M | $672M | $1.22B | $836M | $878M | |
| Long-term Debt | · | · | · | · | · | · | · | $19.09B | $27M | $750M | $750M | $841M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $689M | |
| Common Stock | $198.0K | $193.0K | $224.0K | $223.0K | $221.0K | $219.0K | $216.0K | $213.0K | $211.0K | $189.0K | $187.0K | $171.0K | |
| Retained Earnings | $214M | $-1.07B | $160M | $-437M | $-778M | $-1.73B | $-1.43B | $-1.88B | $-1.99B | $-1.67B | $-1.78B | $-1.79B | |
| AOCI | $25M | $-13M | $13M | $15M | $-19M | $-15M | $-16M | $-10M | $-7M | $-3M | $-809.0K | $2M | |
| Stockholders' Equity | $5.17B | $3.45B | $5.19B | $4.37B | $3.77B | $2.61B | $2.60B | $1.93B | $1.63B | $419M | $171M | $-82M | |
| Liabilities + Equity | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Shares Outstanding | 198,460,009 | 193,434,305 | 224,286,862 | 222,746,719 | 221,084,433 | 219,489,329 | 216,177,830 | 213,274,660 | 211,262,906 | 188,848,752 | 186,650,249 | 170,876,619 |
キャッシュフロー 16
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $93M | $89M | $83M | $68M | $58M | $52M | $55M | $55M | $52M | $58M | $45M | $41M | |
| Stock-based Comp | $249M | $266M | $216M | $188M | $183M | $178M | $167M | $148M | $133M | $96M | $70M | $62M | |
| Deferred Tax | $248M | $-86M | $-159M | $57M | $-466M | $-350.0K | $-377.0K | $-459.0K | $-805.0K | · | · | · | |
| Amort. of Intangibles | $27M | $24M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $13M | · | · | |
| Other Non-cash | $-463M | $33M | · | $316M | $26M | $-58M | $43M | $24M | · | · | · | · | |
| Operating Cash Flow | $1.41B | $335M | $496M | $970M | $749M | $-125M | $711M | $336M | $-93M | $305M | $89M | $26M | |
| CapEx | · | · | · | $78M | $181M | $187M | $78M | $73M | $111M | $120M | $26M | $28M | |
| Investing Cash Flow | $-103M | $158M | $-208M | $-79M | $-208M | $-269M | $-87M | $-86M | $-350M | $-232M | $-105M | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $649M | · | · | · | |
| Stock Repurchased | $0 | $2.00B | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-2.00B | · | · | · | · | · | · | $649M | · | · | · | |
| Financing Cash Flow | $101M | $-2.02B | $-20M | $-794.0K | $6M | $72M | $46M | $15M | $690M | $45M | $85M | · | |
| Net Change in Cash | $1.41B | $-1.53B | $262M | $894M | $544M | $-319M | $669M | $265M | $247M | $117M | $69M | $-19M | |
| Taxes Paid | $212M | $373M | $378M | $136M | $68M | $71M | $34M | $5M | $6M | $927.0K | · | · | |
| Free Cash Flow | · | · | · | $892M | $568M | $-312M | $633M | $263M | $-204M | · | · | $-2M | |
| Levered FCF | · | · | · | $890M | $565M | $-315M | $631M | $261M | $-211M | · | · | $-48M |
収益性 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.5% | 1.5% | · | 17.1% | 19.6% | -9.9% | 18.6% | 6.9% | -15.9% | · | · | -0.94% | |
| Net Margin | 25.0% | 0.77% | · | 10.0% | 31.8% | -11.1% | 20.7% | 5.8% | · | · | · | · | |
| Pretax Margin | 32.4% | 7.5% | · | 15.6% | 19.1% | -8.7% | 22.6% | 6.1% | -20.3% | · | · | -9.5% | |
| EBITDA Margin | 31.3% | 3.5% | · | 19.1% | 21.6% | -7.9% | 21.1% | 9.8% | -12.5% | · | · | 7.2% | |
| ROA | 20.8% | 0.53% | · | 6.3% | 22.3% | -8.5% | 14.7% | 4.4% | · | · | · | · | |
| ROE | 27.6% | 0.99% | · | 7.9% | 27.4% | -11.8% | 17.8% | 5.9% | · | · | · | · | |
| ROIC | 22.7% | 0.18% | · | 8.5% | 25.8% | -12.9% | 14.2% | 6.4% | -15.0% | · | · | -0.79% |
流動性と支払能力 4
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 2.0 | · | 3.5 | 3.7 | 3.7 | 4.8 | 4.3 | 4.0 | · | · | 3.2 | |
| Quick Ratio | 2.0 | 1.0 | · | 2.6 | 2.4 | 2.4 | 4.1 | 3.4 | 3.1 | · | · | 2.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | -8.4 | |
| Interest Coverage | · | · | · | 217.3 | 307.0 | -121.3 | 216.7 | 83.7 | -35.3 | · | · | -0.1 |
効率性 2
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.6 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | 0.7 | |
| Inventory Turnover | 4.7 | 5.1 | · | 5.9 | 6.8 | 9.4 | 12.4 | 14.0 | 15.0 | · | · | 7.9 |
成長率 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 21.2% | 14.8% | 8.9% | 13.7% | 12.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | 12.4% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4173.3% | -94.3% | 74.3% | -64.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 61.6% | -67.2% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3845.0% | -94.5% | 75.4% | -64.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 55.7% | -67.5% | · | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 10
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Net Income TTM | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| Market Cap | $19.60B | $13.36B | · | $17.89B | $16.23B | $19.09B | $18.88B | $13.56B | $20.01B | · | · | · | |
| P/E | 15.4 | 460.5 | 23.7 | 52.8 | 17.2 | -64.0 | 42.6 | 124.7 | -61.9 | 185.7 | 3615.0 | -252.1 | |
| P/S | 3.8 | 3.2 | · | 5.3 | 5.4 | 7.2 | 8.7 | 7.2 | 13.0 | · | · | · | |
| P/B | 3.8 | 3.9 | · | 4.1 | 4.3 | 7.3 | 7.3 | 7.0 | 12.3 | · | · | · | |
| P / Tangible Book | 3.9 | 4.1 | 2.8 | 4.2 | 4.5 | 7.8 | · | · | · | · | · | · | |
| P / Cash Flow | 13.9 | 39.8 | · | 18.4 | 21.7 | -153.2 | 26.6 | 40.3 | -215.2 | · | · | · | |
| P / FCF | · | · | · | 20.1 | 28.5 | -61.2 | 29.8 | 51.6 | -98.1 | · | · | · | |
| Earnings Yield | 6.5% | 0.22% | 4.2% | 1.9% | 5.8% | -1.6% | 2.4% | 0.80% | -1.6% | 0.54% | 0.03% | -0.40% |
損益計算書 17
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.67B | $1.27B | $1.51B | $1.37B | $1.22B | $1.05B | $1.18B | $1.14B | $1.04B | $881M | $1.01B | $919M | $955M | $809M | $927M | $823M | |
| Cost of Revenue | $105M | $105M | $121M | $99M | $79M | $73M | $88M | $86M | $77M | $61M | $70M | $60M | $68M | $57M | $59M | $55M | |
| R&D Expense | $517M | $516M | $611M | $507M | $495M | $437M | $466M | $573M | $1.14B | $429M | $444M | $376M | $401M | $407M | $501M | $384M | |
| SG&A Expense | $352M | $328M | $390M | $329M | $331M | $326M | $327M | $309M | $306M | $300M | $288M | $268M | $284M | $316M | $273M | $266M | |
| Operating Expenses | $976M | $972M | $1.17B | $922M | $685M | $848M | $877M | $992M | $1.52B | $789M | $826M | $704M | $761M | $784M | $857M | $685M | |
| Operating Income | $698M | $301M | $336M | $444M | $530M | $205M | $302M | $146M | $-478M | $92M | $187M | $215M | $194M | $25M | $70M | $138M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $430.0K | · | $623.0K | $655.0K | $469.0K | · | $641.0K | |
| Interest Income | $38M | $34M | $31M | $27M | $25M | $23M | $21M | $19M | $41M | $47M | · | · | · | · | · | · | |
| Other Non-op | $6M | $3M | $6M | $4M | $7M | $8M | $2M | $5M | $8M | $-2M | $-108M | $46M | $43M | $33M | $-14M | $12M | |
| Pretax Income | $752M | $344M | $390M | $482M | $558M | $234M | $314M | $157M | $-390M | $236M | $271M | $234M | $278M | $52M | $81M | $149M | |
| Income Tax | $166M | $40M | $91M | $58M | $153M | $76M | $113M | $50M | $55M | $67M | $70M | $63M | $74M | $30M | $52M | $36M | |
| Net Income | $586M | $303M | $299M | $424M | $405M | $158M | $201M | $106M | $-445M | $170M | $201M | $171M | $204M | $22M | $28M | $113M | |
| EPS (Basic) | $2.92 | $1.52 | $1.51 | $2.17 | $2.09 | $0.82 | $0.89 | $0.55 | $-2.04 | $0.76 | $0.90 | $0.76 | $0.91 | $0.10 | $0.12 | $0.51 | |
| EPS (Diluted) | $2.81 | $1.47 | $1.46 | $2.11 | $2.04 | $0.80 | $0.90 | $0.54 | $-2.04 | $0.75 | $0.89 | $0.76 | $0.90 | $0.10 | $0.13 | $0.50 | |
| Shares (Basic) | 200,378,000 | 199,343,000 | -388,173,000 | 195,670,000 | 193,995,000 | 193,712,000 | -428,178,000 | 192,629,000 | 218,175,000 | 224,484,000 | -446,658,000 | 224,078,000 | 223,248,000 | 222,960,000 | -443,397,000 | 222,415,000 | |
| Shares (Diluted) | 208,216,000 | 206,830,000 | -397,670,000 | 201,429,000 | 198,744,000 | 198,197,000 | -430,702,000 | 195,838,000 | 218,175,000 | 227,219,000 | -451,477,000 | 226,167,000 | 225,649,000 | 225,589,000 | -446,828,000 | 224,175,000 | |
| EBITDA | $698M | $325M | · | $444M | $530M | $228M | · | $146M | $-478M | $114M | · | $215M | $194M | $44M | · | $138M |
貸借対照表 22
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.98B | $3.46B | $3.10B | $2.46B | $1.95B | $1.94B | $1.69B | $1.30B | $987M | $3.35B | · | $3.23B | $3.13B | $2.82B | · | $2.69B | |
| Inventory | $113M | $116M | $101M | $83M | $83M | $64M | $59M | $70M | $101M | $64M | · | $57M | $36M | $41M | · | $46M | |
| Prepaid Expense | $253M | $301M | $318M | $369M | $296M | $212M | $169M | $205M | $208M | $189M | · | $172M | $167M | $194M | · | $180M | |
| Current Assets | $6.03B | $5.48B | $5.02B | $4.28B | $3.64B | $3.51B | $3.24B | $2.81B | $2.57B | $4.85B | · | $4.40B | $4.26B | $3.97B | · | $3.82B | |
| PP&E (Net) | $709M | $720M | $731M | $799M | $799M | $765M | $763M | $773M | $762M | $720M | · | $733M | $749M | $742M | · | $716M | |
| PP&E (Gross) | $1.11B | $1.11B | $1.11B | $1.16B | $1.14B | $1.11B | $1.09B | $1.09B | $1.06B | $1.00B | · | $986M | $988M | $967M | · | $918M | |
| Accum. Depreciation | $404M | $389M | $375M | $361M | $346M | $344M | $328M | $316M | $298M | $283M | · | $253M | $239M | $226M | · | $202M | |
| Goodwill | $133M | $133M | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | $156M | $156M | $156M | · | $156M | |
| Other Non-current Assets | $87M | $24M | $18M | $32M | $33M | $30M | $11M | $40M | $22M | $47M | · | $81M | $32M | $21M | · | $24M | |
| Total Assets | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Accounts Payable | $250M | $229M | $210M | $172M | $241M | $196M | $197M | $179M | $148M | $164M | · | $139M | $156M | $56M | · | $163M | |
| Accrued Liabilities | $870M | $1.09B | $1.03B | $948M | $857M | $1.38B | $1.21B | $1.13B | $1.03B | $1.10B | · | $821M | $811M | $825M | · | $700M | |
| Current Liabilities | $1.31B | $1.49B | $1.52B | $1.34B | $1.28B | $1.72B | $1.64B | $1.50B | $1.34B | $1.40B | · | $1.12B | $1.12B | $1.01B | · | $1.01B | |
| Capital Leases | · | · | $15M | · | · | · | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $125M | $127M | $165M | $171M | $180M | $176M | $168M | $145M | $142M | $151M | · | $133M | $140M | $118M | · | $75M | |
| Total Liabilities | $1.53B | $1.72B | $1.79B | $1.68B | $1.65B | $2.08B | $2.00B | $1.84B | $1.66B | $1.74B | · | $1.46B | $1.47B | $1.34B | · | $1.28B | |
| Common Stock | $201.0K | $200.0K | $198.0K | $196.0K | $194.0K | $193.0K | $193.0K | $192.0K | $191.0K | $224.0K | · | $224.0K | $223.0K | $223.0K | · | $222.0K | |
| Retained Earnings | $1.10B | $517M | $214M | $-86M | $-510M | $-915M | $-1.07B | $-1.27B | $-1.38B | $330M | · | $-41M | $-212M | $-416M | · | $-466M | |
| AOCI | $20M | $22M | $25M | $15M | $13M | $-6M | $-13M | $16M | $-5M | $-6M | · | $23M | $27M | $21M | · | $-29M | |
| Stockholders' Equity | $6.34B | $5.62B | $5.17B | $4.65B | $4.17B | $3.67B | $3.45B | $3.17B | $3.00B | $5.39B | $5.19B | $4.93B | $4.74B | $4.46B | $4.37B | $4.23B | |
| Liabilities + Equity | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Shares Outstanding | 200,977,687 | 199,948,401 | 198,460,009 | 196,130,993 | 194,123,265 | 193,783,446 | 193,434,305 | 192,798,328 | 191,572,449 | 224,533,449 | · | 224,101,839 | 223,338,330 | 223,061,787 | · | 222,454,839 |
キャッシュフロー 10
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $26M | $24M | $24M | $24M | $23M | $22M | $23M | $23M | $22M | $22M | $22M | $21M | $20M | $19M | $18M | $17M | |
| Stock-based Comp | $67M | $64M | $62M | $62M | $65M | $61M | $72M | $78M | $57M | $60M | $60M | $48M | $55M | $53M | $53M | $45M | |
| Other Non-cash | · | $-22M | · | · | · | $25M | · | · | · | $-32M | · | · | · | $-200M | · | · | |
| Operating Cash Flow | $508M | $369M | $543M | $559M | $45M | $266M | $381M | $311M | $-576M | $219M | $148M | $148M | $307M | $-106M | $284M | $296M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $28M | |
| Investing Cash Flow | $-52M | $-88M | $-37M | $-47M | $-19M | $1M | $-21M | $38M | $214M | $-73M | $-154M | $-17M | $-7M | $-29M | $-21M | $-28M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $103.0K | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $65M | $85M | $138M | $-13M | $-11M | $-13M | $20M | $-32M | $-2.00B | $-12M | $346.0K | $-37M | $13M | $4M | $-2M | $-14M | |
| Net Change in Cash | $521M | $363M | $643M | $500M | $13M | $254M | $384M | $317M | $-2.36B | $133M | $-14M | $96M | $310M | $-130M | $261M | $255M | |
| Taxes Paid | $15M | $-9M | $27M | $7M | $177M | $844.0K | $70M | $73M | $227M | $3M | $125M | $116M | $130M | $7M | $20M | $40M |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.7% | 23.7% | · | 32.5% | 43.6% | 19.5% | · | 12.8% | -45.8% | 10.4% | · | 23.4% | 20.3% | 3.1% | · | 16.8% | |
| Net Margin | 35.0% | 23.8% | · | 31.1% | 33.3% | 15.0% | · | 9.4% | -42.6% | 19.2% | · | 18.6% | 21.3% | 2.7% | · | 13.7% | |
| Pretax Margin | 44.9% | 27.0% | · | 35.3% | 45.9% | 22.2% | · | 13.8% | -37.3% | 26.8% | · | 25.4% | 29.1% | 6.4% | · | 18.1% | |
| EBITDA Margin | 41.7% | 25.5% | · | 32.5% | 43.6% | 21.6% | · | 12.8% | -45.8% | 12.9% | · | 23.4% | 20.3% | 5.4% | · | 16.8% | |
| ROA | 8.6% | 4.6% | · | 7.5% | 7.7% | 2.5% | · | 1.9% | -8.2% | 2.6% | · | 2.9% | 3.5% | 0.40% | · | 2.3% | |
| ROE | 11.1% | 6.5% | · | 10.8% | 11.3% | 3.5% | · | 2.6% | -11.5% | 3.4% | · | 3.7% | 4.6% | 0.52% | · | 3.1% | |
| ROIC | 8.6% | 4.7% | · | 8.4% | 9.2% | 3.8% | · | 3.1% | -18.2% | 1.2% | · | 3.2% | 3.0% | 0.23% | · | 2.5% |
流動性と支払能力 3
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 3.7 | · | 3.2 | 2.8 | 2.0 | · | 1.9 | 1.9 | 3.5 | · | 3.9 | 3.8 | 3.9 | · | 3.8 | |
| Quick Ratio | 3.0 | 2.3 | · | 1.8 | 1.5 | 1.1 | · | 0.9 | 0.7 | 2.4 | · | 2.9 | 2.8 | 2.8 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 213.7 | · | 344.6 | 295.8 | 52.8 | · | 215.9 |
効率性 2
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 1.1 | 1.2 | · | 1.3 | 0.9 | 1.1 | · | 1.3 | 1.1 | 1.2 | · | 1.2 | 1.5 | 1.5 | · | 1.6 |
バリュエーション（TTM） 9
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.53B | $4.91B | · | $4.77B | $4.45B | $4.12B | · | $3.98B | $3.80B | $3.56B | · | $3.51B | $3.50B | $3.28B | · | $3.28B | |
| Net Income TTM | $1.72B | $1.29B | · | $1.09B | $225M | $-10M | · | $3M | $100M | $566M | · | $509M | $499M | $334M | · | $494M | |
| Market Cap | $22.78B | $18.82B | · | $16.63B | $13.22B | $11.73B | · | $12.74B | $11.61B | $12.79B | · | $12.95B | $13.90B | $16.12B | · | $14.82B | |
| P/E | 13.4 | 14.7 | · | 15.4 | 50.8 | 1211.0 | · | 6610.0 | 163.8 | 22.7 | · | 25.6 | 28.0 | 48.5 | · | 30.2 | |
| P/S | 4.1 | 3.8 | · | 3.5 | 3.0 | 2.9 | · | 3.2 | 3.1 | 3.6 | · | 3.7 | 4.0 | 4.9 | · | 4.5 | |
| P/B | 3.6 | 3.3 | · | 3.6 | 3.2 | 3.2 | · | 4.0 | 3.9 | 2.4 | · | 2.6 | 2.9 | 3.6 | · | 3.5 | |
| P / Tangible Book | 3.7 | 3.4 | · | 3.7 | 3.3 | 3.3 | · | 4.2 | 4.1 | 2.4 | · | 2.7 | 3.0 | 3.7 | · | 3.6 | |
| P / Cash Flow | · | 51.0 | · | · | · | 44.1 | · | · | · | 58.5 | · | · | · | -152.7 | · | · | |
| Earnings Yield | 7.4% | 6.8% | · | 6.5% | 2.0% | 0.08% | · | 0.02% | 0.61% | 4.4% | · | 3.9% | 3.6% | 2.1% | · | 3.3% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B |
| 営業利益率 % | 29.5% | 1.5% | — | 17.1% | 19.6% |
| 純利益 | $1.29B | $33M | $598M | $341M | $949M |
| 希薄化後EPS | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流動比率 | 3.3 | 2.0 | — | 3.5 | 3.7 |
| クイックレシオ | 2.0 | 1.0 | — | 2.6 | 2.4 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | — | — | — | $892M | $568M |
最新ニュース この会社に言及した最近の見出し
トレードシグナル エントリー価格とリスク/リワード比率を伴う最近の売買シグナル
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
📊
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 928 提出者 · $16.2B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 129 (+10 前期比) | 66 (-31 前期比) | 345 (+31 前期比) | 261 (-21 前期比) | +18.0M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $3,487,217,729 | 30,762,330 | 21.56% | 株式数 |
| Dodge & Cox | $1,355,482,475 | 11,957,326 | 8.38% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,249,713,401 | 11,024,289 | 7.73% | 株式数 |
| STATE STREET CORP | $1,102,124,009 | 9,722,336 | 6.81% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $883,198,076 | 7,791,091 | 5.46% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $472,254,570 | 4,183,857 | 2.92% | 株式数 |
| RENAISSANCE TECHNOLOGIES LLC | $398,135,284 | 3,512,132 | 2.46% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $384,786,803 | 3,394,379 | 2.38% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $311,168,439 | 2,744,958 | 1.92% | 株式数 |
| Robeco Institutional Asset Management B.V. | $276,795,075 | 2,441,735 | 1.71% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $227,123,448 | 2,003,559 | 1.40% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $201,199,603 | 1,774,874 | 1.24% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $191,845,249 | 1,692,354 | 1.19% | 株式数 |
| FIRST TRUST ADVISORS LP | $180,015,041 | 1,587,996 | 1.11% | 株式数 |
| VICTORY CAPITAL MANAGEMENT INC | $167,811,569 | 1,480,342 | 1.04% | 株式数 |
| Caisse de depot et placement du Quebec | $155,360,220 | 1,370,503 | 0.96% | 株式数 |
| AustralianSuper Pty Ltd | $135,634,220 | 1,196,491 | 0.84% | 株式数 |
| NORGES BANK | $126,861,970 | 1,119,107 | 0.78% | 株式数 |
| FMR LLC | $116,316,542 | 1,026,081 | 0.72% | 株式数 |
| ROYAL BANK OF CANADA | $115,263,000 | 1,016,790 | 0.71% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $106,959,694 | 943,540 | 0.66% | 株式数 |
| ARMISTICE CAPITAL, LLC | $102,024,567 | 900,005 | 0.63% | 株式数 |
| PANAGORA ASSET MANAGEMENT INC | $99,970,937 | 881,889 | 0.62% | 株式数 |
| GOLDMAN SACHS GROUP INC | $97,568,045 | 860,692 | 0.60% | 株式数 |
| VANGUARD GROUP INC | $91,396,622 | 925,348 | 0.56% | 株式数 |
| Sound Shore Management Inc /CT/ | $85,895,479 | 757,723 | 0.53% | 株式数 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $82,953,901 | 731,774 | 0.51% | 株式数 |
| Gotham Asset Management, LLC | $81,567,621 | 719,545 | 0.50% | 株式数 |
| Pictet Asset Management Holding SA | $81,315,880 | 713,354 | 0.50% | 株式数 |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $75,887,460 | 768,325 | 0.47% | 株式数 |
| MACKENZIE FINANCIAL CORP | $71,967,956 | 634,862 | 0.44% | 株式数 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $65,633,852 | 578,986 | 0.41% | 株式数 |
| Legal & General Group Plc | $63,331,398 | 558,675 | 0.39% | 株式数 |
| SEB Asset Management AB | $63,307,742 | 558,467 | 0.39% | 株式数 |
| GLENMEDE TRUST CO NA | $60,308,653 | 532,010 | 0.37% | 株式数 |
| Woodline Partners LP | $58,118,538 | 512,690 | 0.36% | 株式数 |
| MARSHALL WACE, LLP | $56,804,130 | 501,095 | 0.35% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $56,779,870 | 500,881 | 0.35% | 株式数 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $55,184,782 | 486,810 | 0.34% | 株式数 |
| BlackRock, Inc. | $54,675,002 | 482,313 | 0.34% | 株式数 |
| Swiss National Bank | $54,058,437 | 476,874 | 0.33% | 株式数 |
| Glenmede Investment Management, LP | $53,145,338 | 626,640 | 0.33% | 株式数 |
| Vinva Investment Management Ltd | $53,069,578 | 462,843 | 0.33% | 株式数 |
| CANADA PENSION PLAN INVESTMENT BOARD | $50,161,800 | 442,500 | 0.31% | 株式数 |
| California Public Employees Retirement System | $48,730,290 | 429,872 | 0.30% | 株式数 |
| RHUMBLINE ADVISERS | $48,578,406 | 428,533 | 0.30% | 株式数 |
| IEQ CAPITAL, LLC | $48,141,997 | 424,682 | 0.30% | 株式数 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $46,733,567 | 412,258 | 0.29% | 株式数 |
| Sumitomo Mitsui Trust Group, Inc. | $44,634,140 | 393,738 | 0.28% | 株式数 |
| Vanguard Global Advisers, LLC | $43,080,994 | 380,037 | 0.27% | 株式数 |
| MORGAN STANLEY | $42,894,746 | 378,394 | 0.27% | 株式数 |
| Swedbank AB | $42,100,431 | 371,387 | 0.26% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $39,177,443 | 345,602 | 0.24% | 株式数 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $38,530,157 | 339,892 | 0.24% | 株式数 |
| CAPITAL FUND MANAGEMENT S.A. | $38,125,008 | 336,318 | 0.24% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $37,984,782 | 335,081 | 0.23% | 株式数 |
| Grantham, Mayo, Van Otterloo & Co. LLC | $36,114,682 | 318,584 | 0.22% | 株式数 |
| Aware Super Pty Ltd as trustee of Aware Super | $34,779,982 | 306,810 | 0.21% | 株式数 |
| Arbejdsmarkedets Tillaegspension | $33,826,624 | 298,400 | 0.21% | 株式数 |
| BARCLAYS PLC | $32,329,252 | 285,191 | 0.20% | 株式数 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $32,129,398 | 283,428 | 0.20% | 株式数 |
| Ensign Peak Advisors, Inc | $30,602,212 | 269,956 | 0.19% | 株式数 |
| Illinois Municipal Retirement Fund | $29,511,916 | 260,338 | 0.18% | 株式数 |
| WINTON GROUP Ltd | $28,839,691 | 254,408 | 0.18% | 株式数 |
| PFA Pension, Forsikringsaktieselskab | $28,624,373 | 252,509 | 0.18% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $26,717,581 | 236,172 | 0.17% | 株式数 |
| TODD ASSET MANAGEMENT LLC | $26,568,750 | 234,375 | 0.16% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $25,899,133 | 228,468 | 0.16% | 株式数 |
| PRINCIPAL FINANCIAL GROUP INC | $24,961,078 | 220,193 | 0.15% | 株式数 |
| Andra AP-fonden | $24,381,598 | 259,048 | 0.15% | 株式数 |
| Quantinno Capital Management LP | $24,309,704 | 214,446 | 0.15% | 株式数 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $24,037,194 | 212,043 | 0.15% | 株式数 |
| Baird Financial Group, Inc. | $23,690,539 | 208,985 | 0.15% | 株式数 |
| Eurizon Capital SGR S.p.A. | $23,250,000 | 204,785 | 0.14% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $22,709,932 | 241,287 | 0.14% | 株式数 |
| Korea Investment CORP | $22,164,827 | 195,526 | 0.14% | 株式数 |
| KLP KAPITALFORVALTNING AS | $21,799,695 | 192,305 | 0.13% | 株式数 |
| Catalio Capital Management, LP | $21,722,837 | 191,627 | 0.13% | 株式数 |
| PRUDENTIAL FINANCIAL INC | $21,650,853 | 190,992 | 0.13% | 株式数 |
| ROYAL LONDON ASSET MANAGEMENT LTD | $21,575,016 | 190,323 | 0.13% | 株式数 |
| Fideuram Asset Management (Ireland) dac | $20,928,446 | 213,883 | 0.13% | 株式数 |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $20,401,285 | 179,969 | 0.13% | 株式数 |
| APG Asset Management N.V. | $20,193,310 | 203,661 | 0.12% | 株式数 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $19,499,734 | 172,016 | 0.12% | 株式数 |
| SECTOR GAMMA AS | $19,356,560 | 170,753 | 0.12% | 株式数 |
| MARTINGALE ASSET MANAGEMENT L P | $19,137,209 | 168,818 | 0.12% | 株式数 |
| CWM, LLC | $19,084,906 | 202,772 | 0.12% | 株式数 |
| Bridgewater Associates, LP | $19,073,160 | 168,253 | 0.12% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $18,937,791 | 201,209 | 0.12% | 株式数 |
| Candriam S.C.A. | $18,443,367 | 162,854 | 0.11% | 株式数 |
| Focus Partners Wealth | $18,354,947 | 161,917 | 0.11% | 株式数 |
| DNB Asset Management AS | $18,304,239 | 161,470 | 0.11% | 株式数 |
| SEI INVESTMENTS CO | $18,019,140 | 158,955 | 0.11% | 株式数 |
| Trails Edge Capital Partners, LP | $17,570,800 | 155,000 | 0.11% | 株式数 |
| Jefferies Financial Group Inc. | $17,321,295 | 152,799 | 0.11% | 株式数 |
| SAWGRASS ASSET MANAGEMENT LLC | $17,250,671 | 152,176 | 0.11% | 株式数 |
| Mitsubishi UFJ Trust & Banking Corp | $17,215,756 | 151,868 | 0.11% | 株式数 |
| AVIVA PLC | $16,882,025 | 148,924 | 0.10% | 株式数 |
| Driehaus Capital Management LLC | $16,794,397 | 148,151 | 0.10% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $16,681,037 | 147,151 | 0.10% | 株式数 |
企業インサイダー 61 人のインサイダー · 32人の役員 · 17人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| William Meury | Chief Executive Officer | 2026年7月16日 A | 183,129 | 0 | 0 | $0 |
| Herve Hoppenot | Special Advisor to the CEO | 2025年7月15日 F | 517,146 | 0 | 0 | $0 |
| Christiana Stamoulis | EVP & Chief Financial Officer | 2025年7月15日 A | 125,759 | 0 | 0 | $0 |
| David W Gryska | Executive Vice President, CFO | 2018年7月16日 F | 10,235 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 2014年6月5日 M | 8,500 | 0 | 0 | $0 |
| Lee Heeson | EVP, Head of Incyte Intl | 2026年7月23日 A | 32,778 | 0 | 0 | $0 |
| Michael James Morrissey | EVP, Head of Tech. Operations | 2026年7月23日 A | 81,515 | 0 | 0 | $0 |
| Richard A. Hoffman | EVP & General Counsel | 2026年7月16日 A | 16,861 | 0 | 0 | $0 |
| David H Gardner | EVP, Chief Strategy Officer | 2026年7月16日 A | 16,824 | 0 | 0 | $0 |
| Ramitpal K Basi | EVP, Human Resources | 2026年7月16日 A | 11,497 | 0 | 0 | $0 |
| Mohamed Khairie Issa | EVP, Head of U.S. Commercial | 2026年7月16日 A | 71,797 | 0 | 1 | $-125,706 |
| Thomas Tray | Principal Accounting Officer | 2026年7月16日 A | 21,699 | 0 | 1 | $-263,900 |
| Steven H Stein | CMO & Head of Late-Stage Dev. | 2026年7月16日 A | 30,916 | 0 | 2 | $-3,407,541 |
| Sheila A. Denton | EVP & General Counsel | 2025年8月15日 M | 33,200 | 0 | 1 | $-24,046 |
| Vijay K Iyengar | EVP, GMAPPS | 2025年7月16日 S | 40,540 | 0 | 0 | $0 |
| Barry P Flannelly | EVP & General Manager US | 2025年7月16日 S | 35,149 | 0 | 0 | $0 |
| Matteo Trotta | EVP, GM, Dermatology US | 2025年7月15日 A | 15,016 | 0 | 0 | $0 |
| Paula J Swain | EVP, Human Resources | 2025年7月15日 A | 106,482 | 0 | 0 | $0 |
| Jonathan Elliott Dickinson | EVP, General Manager, Europe | 2024年9月12日 S | 36,390 | 0 | 0 | $0 |
| Dashyant Dhanak | EVP & Chief Scientific Officer | 2023年7月14日 A | 58,968 | 0 | 0 | $0 |
| Maria E Pasquale | EVP & General Counsel | 2023年7月14日 A | 69,724 | 0 | 0 | $0 |
| Paul Trower | Principal Accounting Officer | 2022年1月19日 A | 32,268 | 0 | 0 | $0 |
| Yao Wenqing | EVP, Head of Discovery Chem | 2021年7月2日 A | 98,575 | 0 | 0 | $0 |
| Reid M Huber | EVP, Chief Scientific Officer | 2018年7月16日 F | 34,571 | 0 | 0 | $0 |
| Eric H. Siegel | EVP, General Counsel | 2017年9月13日 F | 21,053 | 0 | 0 | $0 |
| Richard S Levy | EVP, Chief Drug Dev Officer | 2016年1月6日 M | 16,926 | 0 | 0 | $0 |
| James M Daly | EVP, Chief Commercial Officer | 2015年6月23日 M | 3,521 | 0 | 0 | $0 |
| Patricia S Andrews | Chief Commercial Officer | 2012年1月19日 A | — | 0 | 0 | $0 |
| Patricia A Schreck | EVP, General Counsel | 2011年5月10日 M | 4,500 | 0 | 0 | $0 |
| Brian W Metcalf | Chief Drug Discovery Scientist | 2011年4月11日 M | 66,504 | 0 | 0 | $0 |
| Steven M. Friedman | EVP, Biology & Preclinical Dev | 2010年5月18日 A | 38,137 | 0 | 0 | $0 |
| John A Keller | Chief Business Officer | 2008年2月8日 A | — | 0 | 0 | $0 |
| Paul J Clancy | 取締役 | 2026年6月30日 A | 25,635 | 0 | 0 | $0 |
| Edmund Harrigan | 取締役 | 2026年6月30日 A | 23,019 | 0 | 0 | $0 |
| Katherine A High | 取締役 | 2026年6月8日 A | 14,983 | 0 | 0 | $0 |
| Jacqualyn A Fouse | 取締役 | 2026年6月8日 A | 20,968 | 0 | 0 | $0 |
| Jean Jacques Bienaime | 取締役 | 2026年6月8日 A | 24,424 | 0 | 0 | $0 |
| Otis W Brawley | 取締役 | 2026年6月8日 A | 12,894 | 0 | 0 | $0 |
| Susanne Schaffert | 取締役 | 2024年6月12日 A | 5,720 | 0 | 0 | $0 |
| Wendy L Dixon | 取締役 | 2022年3月31日 A | 17,768 | 0 | 0 | $0 |
| Paul A Friedman, M.D. | 取締役 | 2020年5月26日 A | 256,813 | 0 | 0 | $0 |
| Paul A Brooke | 取締役 | 2020年3月31日 A | 221,911 | 0 | 0 | $0 |
| Barry A Ariko | 取締役 | 2015年3月12日 M | 45,834 | 0 | 0 | $0 |
| Richard U De Schutter | 取締役 | 2015年3月5日 M | 92,290 | 0 | 0 | $0 |
| Roy A Whitfield | 取締役 | 2013年12月17日 M | 666,082 | 0 | 0 | $0 |
| John F Niblack | 取締役 | 2011年5月20日 A | — | 0 | 0 | $0 |
| Fred B Craves | 取締役 | 2005年6月1日 A | 196,793 | 0 | 0 | $0 |
| INCYTE CORP | 10%オーナー | 2021年1月25日 A | 3,550,000 | 0 | 0 | $0 |
| DAMIAL FOUNDATION INC | 10%オーナー | 2004年2月11日 S | — | 0 | 0 | $0 |
| Bonnie J Tisch | 10%オーナー | 2004年1月14日 S | — | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 7保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB3 LLC, FBB Associates ×21 提出書類 | 2026年5月11日 | 15.60% | 修正 | 受動的投資 | SEC |
| Incyte Corporation ×3 提出書類 | 2023年8月14日 | — | 初回提出 | 資本構成 | SEC |
| Baker Bros. Advisors, LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB Associates ×2 提出書類 | 2012年6月15日 | — | 初回提出 | — | SEC |
| Julian C. Baker, Felix J. Baker ×12 提出書類 | 2009年10月1日 | — | 初回提出 | — | SEC |
| 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者 | 2004年2月25日 | — | 初回提出 | — | SEC |
| 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者 | 2003年9月29日 | — | 初回提出 | — | SEC |
| 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者 | 2002年8月15日 | — | 初回提出 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 214のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| IDNA · iShares Trust | 4.05% | 67,570 SH | 2026年8月8日 | 日次 |
| BRNY · EA Series Trust | 3.64% | 211,562 NS | 2026年4月30日 | N-PORT |
| PBE · Invesco Exchange-Traded Fund Trust | 2.97% | 89,311 SH | 2026年8月8日 | 日次 |
| BUL · Pacer Funds Trust | 2.38% | 31,787 NS | 2026年4月30日 | N-PORT |
| SAWG · ETF Series Solutions | 2.36% | 624 NS | 2026年4月30日 | N-PORT |
| UPGD · Invesco Exchange-Traded Fund Trust | 2.32% | 23,365 SH | 2026年8月8日 | 日次 |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.19% | 201,047 NS | 2026年4月30日 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1.98% | 623 NS | 2026年4月30日 | N-PORT |
| SMRI · EA Series Trust | 1.96% | 111,283 NS | 2026年4月30日 | N-PORT |
| IBB · iShares Trust | 1.81% | 1,453,479 SH | 2026年8月8日 | 日次 |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.78% | 9,967 NS | 2026年4月30日 | N-PORT |
| RPG · Invesco Exchange-Traded Fund Trust | 1.75% | 293,364 SH | 2026年8月8日 | 日次 |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.75% | 337,040 SH | 2026年8月8日 | 日次 |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.73% | 112,472 SH | 2026年8月8日 | 日次 |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1.64% | 10,873 SH | 2026年8月8日 | 日次 |
| BBP · ETFis Series Trust I | 1.59% | 9,918 NS | 2026年4月30日 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1.59% | 736 NS | 2026年4月30日 | N-PORT |
| CALF · Pacer Funds Trust | 1.55% | 561,166 NS | 2026年4月30日 | N-PORT |
| NUMG · Nushares ETF Trust | 1.44% | 53,580 NS | 2026年4月30日 | N-PORT |
| AGNG · Global X Funds | 1.36% | 11,515 NS | 2026年5月31日 | N-PORT |
| COWG · Pacer Funds Trust | 1.21% | 275,493 NS | 2026年4月30日 | N-PORT |
| FLOW · Global X Funds | 1.20% | 3,543 NS | 2026年5月31日 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1.16% | 113,960 SH | 2026年8月8日 | 日次 |
| GURU · Global X Funds | 1.01% | 6,203 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.97% | 7,359 NS | 2026年5月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.94% | 51,287 NS | 2026年4月30日 | N-PORT |
| TMFX · RBB Fund, Inc. | 0.94% | 3,113 NS | 2026年5月31日 | N-PORT |
| OASC · Unified Series Trust | 0.91% | 7,915 NS | 2026年5月31日 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.89% | 56,482 NS | 2026年4月30日 | N-PORT |
| ROE · EA Series Trust | 0.87% | 23,347 NS | 2026年5月29日 | N-PORT |
| JMID · Janus Detroit Street Trust | 0.83% | 1,595 NS | 2026年4月30日 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0.80% | 8,654 SH | 2026年8月8日 | 日次 |
| JOET · Virtus ETF Trust II | 0.79% | 19,541 NS | 2026年4月30日 | N-PORT |
| INFO · Harbor ETF Trust | 0.75% | 61,119 NS | 2026年4月30日 | N-PORT |
| CLSE · Trust for Professional Managers | 0.71% | 45,326 NS | 2026年5月31日 | N-PORT |
| SDG · iShares Trust | 0.70% | 10,188 SH | 2026年8月8日 | 日次 |
| FTC · First Trust Exchange-Traded AlphaDE… | 0.64% | 85,796 NS | 2026年4月30日 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 0.64% | 146,423 NS | 2026年5月31日 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.53% | 2,249,253 SH | 2026年8月8日 | 日次 |
| EBI · RBB Fund Trust | 0.52% | 35,279 NS | 2026年5月31日 | N-PORT |
| ESMV · iShares Trust | 0.51% | 339 SH | 2026年8月8日 | 日次 |
| TECB · iShares Trust | 0.48% | 19,516 SH | 2026年8月8日 | 日次 |
| AFMC · First Trust Exchange-Traded Fund VI… | 0.48% | 7,994 NS | 2026年5月31日 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0.46% | 19,147 SH | 2026年8月8日 | 日次 |
| USMV · iShares Trust | 0.45% | 918,818 SH | 2026年8月8日 | 日次 |
| AFLG · First Trust Exchange-Traded Fund VI… | 0.45% | 29,860 NS | 2026年5月31日 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0.44% | 4,411 NS | 2026年5月31日 | N-PORT |
| COWZ · Pacer Funds Trust | 0.44% | 832,413 NS | 2026年4月30日 | N-PORT |
| QQWZ · Pacer Funds Trust | 0.43% | 2,130 NS | 2026年4月30日 | N-PORT |
| HQGO · Lattice Strategies Trust | 0.42% | 2,110 NS | 2026年4月30日 | N-PORT |